Celularity Inc. (CELU)
Nasdaq: CELU · Pharmaceutical Preparations · Florham Park, NJ · filing with the SEC since 2018
Who owns Celularity Inc.
As filed with the SECHolders of 5% or more
2
Lim Kok Thay holds 41% of Class A Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Jul 28, 2025 says.
Directors and officers
10
report now, of 29 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Lim Kok Thay
SCHEDULE 13D/A · filed Jul 28, 2025 · Class A Common Stock, par value $0.0001 per share · 36.4% in Jan 28, 2025
Philip & Daniele Barach Family Trust
SCHEDULE 13D/A · filed Sep 28, 2026 · Class A Common Stock, Par Value $0.0001 Per Share · 15.8% in Jun 23, 2026
Bristol-Myers Squibb Co.
SCHEDULE 13G/A · filed Feb 14, 2025 · Class A Common stock, par value $0.0001 per share · reported falling below 5%
Lincoln Alternative Strategies LLC
SCHEDULE 13G/A · filed Feb 11, 2026 · Class A Common Stock, $0.0001 par value per share · reported falling below 5%, from 5.14% in Aug 27, 2025
What CELU reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Sequence LifeScience Inc
A company bought · asset acquisition · owns, named in the 10-K filed Apr 30, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2023 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.